CareCloud Launches Healthcare AI Center Set to Become World’s Largest with 500 AI Professionals

SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and generative AI solutions, today announced the official launch of its AI Center of Excellence (the “AI CoE”) — a major strategic initiative aimed at delivering scalable, domain-specific artificial intelligence solutions purpose-built for healthcare.

“Our ground-breaking AI Center officially began operations earlier this month with an inaugural team of over 50 AI engineers, data scientists, and healthcare domain experts, marking a pivotal moment in CareCloud’s journey,” said Hadi Chaudhry, Co-CEO of CareCloud. “The AI Center of Excellence reflects our long-term vision to lead in healthcare transformation. By leveraging 25 years of clinical and financial data, CareCloud is building proprietary, purpose-driven AI solutions that empower providers to deliver better care—faster, smarter, and more efficiently.”

The AI CoE operates under a dual-shore model, seamlessly combining global engineering talent with localized healthcare expertise. CareCloud plans to scale the team to 500 AI professionals between now and the fourth quarter of 2025 — a milestone that CareCloud believes will establish it as the largest dedicated healthcare AI initiative in the world. The AI CoE is fully self-funded, reflecting CareCloud’s strong operating cash flows, disciplined execution, and the scalability of its global delivery model. By leveraging a highly efficient cost structure that outperforms U.S.-based competitors, CareCloud is uniquely positioned to accelerate innovation at scale while delivering enterprise-grade solutions with exceptional cost-effectiveness.

“The launch of CareCloud’s AI Center of Excellence marks a major step forward in our growth strategy,” said Stephen Snyder, Co-CEO of CareCloud. “RCM companies and other industry competitors without advanced AI capabilities are being left behind — survival and growth now depend on innovation at scale. With the launch of our AI Center of Excellence, CareCloud is not just adapting to this shift — we are driving it. By embedding AI across every level of our organization, we are building a more powerful, efficient, and future-ready company positioned to lead the next era of healthcare.”

Some core focus areas of CareCloud’s AI CoE include:

• Proprietary Healthcare AI Models: Developing intelligent, domain-specific models for clinical workflows, revenue cycle processes, and decision support.
• Automation and Efficiency Gains: Streamlining clinical documentation, coding, claims management, prior authorizations, and compliance workflows.
• Predictive and Preventive Analytics: Enabling earlier identification of reimbursement risks, denial causes, patient propensity-to-pay and operational bottlenecks.
• Smarter Patient and Provider Engagement: Enhancing communication, scheduling, patient education, and satisfaction through AI-driven personalization.
• Accelerated Innovation Across Platforms: Embedding AI natively across EHR, RCM, and digital health products to deliver real-time, scalable value.
  
  

CareCloud’s deep domain expertise and rich historical datasets provide a significant advantage in training and refining accurate, compliant AI models. By tightly integrating AI across its technology stack, the company is poised to deliver enterprise-grade, HIPAA-compliant solutions with immediate real-world impact.

As the healthcare industry rapidly embraces artificial intelligence, CareCloud’s AI CoE strengthens its role as an innovation leader — driving operational transformation, enhancing clinical outcomes, and reducing the administrative burden on providers.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at .

Follow CareCloud on ,  and .

For additional information, please visit our website at . To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit .

Disclaimer

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

Forward-Looking Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

SOURCE CareCloud

Company Contact: 

Norman Roth 

Interim Chief Financial Officer and Corporate Controller 

CareCloud, Inc.

 

Investor Contact:

Stephen Snyder 

Co-Chief Executive Officer 

CareCloud, Inc.